Schallenberger Mark A.'s Form 4 filing
Xtant Medical Holdings, Inc. (XTNT) · filed Aug 18, 2026
- Accession no.
- 0001960742-26-000002
- Filed
- Aug 18, 2026, 6:02 PM ET
- Trade date
- Aug 15, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schallenberger Mark A.CIK 0001960742 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2026 | Common Stock | AGrant or awardAcquired | +450,000 | $0.00 | $0 | 1,113,157 | Direct | |
| Aug 15, 2026 | Common Stock | FTax withholdingDisposed | −7,070 | $0.31 | −$2,191.7 | 1,106,087 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.